Literature DB >> 11898853

Regulation of L-arginine transport and metabolism in vascular smooth muscle cells.

W Durante1.   

Abstract

L-Arginine is a semi-essential amino acid that is metabolized to important regulatory molecules. L-Arginine is transported into vascular smooth muscle cells (SMC) by the cationic amino acid transporter (CAT) family of proteins where it is metabolized to nitric oxide (NO), polyamines, or L-proline. Inflammatory mediators, growth factors, and hemodynamic forces stimulate the transport of L-arginine in vascular SMC by inducing CAT gene expression. However, they exert highly specific and divergent regulatory effects on L-arginine metabolism. Inflammatory cytokines induce the expression of inducible NO synthase (iNOS) and direct the metabolism of L-arginine to the antiproliferative gas, NO. In contrast, growth factors stimulate the expression of arginase I and ornithine decarboxylase (ODC) and channel the metabolism of L-arginine to growth stimulatory polyamines. Alternatively, cyclic mechanical strain blocks both iNOS and ODC activity and stimulates arginase I gene expression, directing the metabolism of L-arginine to the formation of L-proline and collagen. Thus, specific biochemical and biophysical stimuli that are found in the circulation regulate the transport and metabolism of L-arginine in vascular SMC. The ability of these physiologically relevant stimuli to upregulate L-arginine transport and generate specific L-arginine metabolites modulates SMC function and may influence the development of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11898853     DOI: 10.1385/CBB:35:1:19

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  9 in total

Review 1.  Arginase: a critical regulator of nitric oxide synthesis and vascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-09       Impact factor: 2.557

2.  Arginine supplementation induces myoblast fusion via augmentation of nitric oxide production.

Authors:  Jodi H D Long; Vitor A Lira; Quinlyn A Soltow; Jenna L Betters; Jeff E Sellman; David S Criswell
Journal:  J Muscle Res Cell Motil       Date:  2006-10-19       Impact factor: 2.698

3.  Arginase type I as a marker of coronary heart disease in hemodialysis patients.

Authors:  Theodoros Eleftheriadis; Vassilios Liakopoulos; Georgia Antoniadi; Ioannis Stefanidis; Grammati Galaktidou
Journal:  Int Urol Nephrol       Date:  2010-09-15       Impact factor: 2.370

4.  Effects of L-arginine on spontaneous contraction of the rat portal vein.

Authors:  Keiichi Shimamura; Ming Zhou; Miyuki Toba; Shinichi Kimura; Takashiro Higuchi; Hideaki Kawaguchi; Fumiko Sekiguchi; Satoru Sunano
Journal:  Pflugers Arch       Date:  2003-03-08       Impact factor: 3.657

5.  Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.

Authors:  Nicole Lüneburg; Wolfgang Lieb; Tanja Zeller; Ming-Huei Chen; Renke Maas; Angela M Carter; Vanessa Xanthakis; Nicole L Glazer; Edzard Schwedhelm; Sudha Seshadri; Mohammad Arfan Ikram; William T Longstreth; Myriam Fornage; Inke R König; Christina Loley; Francisco M Ojeda; Arne Schillert; Thomas J Wang; Heinrich Sticht; Anja Kittel; Jörg König; Emelia J Benjamin; Lisa M Sullivan; Isabel Bernges; Maike Anderssohn; Andreas Ziegler; Christian Gieger; Thomas Illig; Christa Meisinger; H-Erich Wichmann; Philipp S Wild; Heribert Schunkert; Bruce M Psaty; Kerri L Wiggins; Susan R Heckbert; Nicholas Smith; Karl Lackner; Kathryn L Lunetta; Stefan Blankenberg; Jeanette Erdmann; Thomas Munzel; Peter J Grant; Ramachandran S Vasan; Rainer H Böger
Journal:  Circ Cardiovasc Genet       Date:  2014-09-21

Review 6.  The Emerging Role of l-Glutamine in Cardiovascular Health and Disease.

Authors:  William Durante
Journal:  Nutrients       Date:  2019-09-04       Impact factor: 5.717

7.  Role of arginase in vessel wall remodeling.

Authors:  William Durante
Journal:  Front Immunol       Date:  2013-05-13       Impact factor: 7.561

8.  Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.

Authors:  Adrian T Gonon; Christian Jung; Abram Katz; Håkan Westerblad; Alexey Shemyakin; Per-Ove Sjöquist; Jon O Lundberg; John Pernow
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

Review 9.  Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy.

Authors:  William Durante
Journal:  Metabolites       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.